Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Analyst Roundtable: Med-Tech Industry Outlook For 2008

This article was originally published in The Gray Sheet

Executive Summary

Diagnostics, neurostimulation and atrial fibrillation are among device segments with growth potential in 2008, according to device industry analysts who spoke with "The Gray Sheet" in December about prospects for the year ahead

You may also be interested in...



Too Many Heart Failure Patients Missing Out On Proven Therapies – HFSA

Hospitals should build interdisciplinary heart failure management teams to ensure all heart failure patients receive appropriate evidence-based care, heart failure specialists and quality researchers agreed at the recent Heart Failure Society of America meeting in Toronto

Too Many Heart Failure Patients Missing Out On Proven Therapies – HFSA

Hospitals should build interdisciplinary heart failure management teams to ensure all heart failure patients receive appropriate evidence-based care, heart failure specialists and quality researchers agreed at the recent Heart Failure Society of America meeting in Toronto

Hospital Suppliers Show Vigor In ’07, With Prospects Strong For ’08 – Index

Baxter and Becton Dickinson were among large-cap hospital supply firms to prove that boring can be beautiful in 2007, as med-tech investors turned off by volatility in the sexier cardiac implant sector turned on to the relative stability of diversified, low-risk hospital products with respectable growth

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT025611

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel